Clinical trial
Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine in Patients With Mild to Moderate Hypertension, Hyperhomocysteinemia and Angiotension-Converting Enzyme Inhibitor Intolerance
NCT01956786 is registered in ClinicalTrials.gov with Shenzhen Ausa Pharmed Co.,Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine in Patients With Mild to Moderate Hypertension, Hyperhomocysteinemia and Angiotension-Converting Enzyme Inhibitor Intolerance
- Lead sponsor
- Shenzhen Ausa Pharmed Co.,Ltd
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- September 30, 2013
- Completion date
- February 28, 2014
- Enrollment
- 540 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.